What are the considerations for Endoscopic Retrograde Cholangiopancreatography (ERCP) with Endoscopic Papillary Balloon Dilation (EPBD) in a patient with a history of coagulopathy, liver disease, or previous pancreatic surgery?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: January 16, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

ERCP with Endoscopic Papillary Balloon Dilation (EPBD): Key Considerations

In patients with coagulopathy or liver disease, EPBD without prior sphincterotomy is the preferred approach over standard sphincterotomy to minimize bleeding risk, using an 8 mm diameter balloon with inflation maintained ≥1 minute. 1

Primary Indication for EPBD

EPBD is strongly recommended as an adjunct to biliary sphincterotomy for facilitating removal of large common bile duct stones. 1 This represents high-quality evidence with strong recommendation from the British Society of Gastroenterology (BSG) guidelines. 1

EPBD in High-Risk Patients

Coagulopathy and Liver Disease

EPBD without prior sphincterotomy should be considered as the primary alternative to biliary sphincterotomy in patients with uncorrected coagulopathy. 1 This approach significantly reduces hemorrhage risk compared to sphincterotomy:

  • Meta-analysis data demonstrates EPBD is associated with lower incidence of hemorrhage versus sphincterotomy 1
  • Network meta-analysis shows prolonged EPBD (>1 minute) has 90.3% probability of being the safest treatment regarding overall complications 1
  • Clinically significant hemorrhage occurs in 0.1-2% of sphincterotomies, with coagulopathy being a major risk factor 1

Mandatory pre-procedure testing includes full blood count (FBC) and INR/PT prior to ERCP for ductal stones. 1 If deranged clotting or thrombocytopenia is identified, management should conform to local guidelines. 1

Patients on warfarin, antiplatelet therapy, or direct oral anticoagulants (DOACs) must be managed according to combined BSG/ESGE guidelines for endoscopy. 1

Altered Anatomy (Previous Pancreatic Surgery)

EPBD without sphincterotomy is specifically recommended for patients with difficult biliary access due to altered anatomy. 1 This includes patients with previous gastroenteric anastomoses where standard ERCP is technically challenging. 1

Critical Technical Requirements for EPBD

When performing EPBD without prior sphincterotomy, use an 8 mm diameter balloon and maintain inflation ≥1 minute following waist disappearance. 1 This prolonged inflation technique reduces post-ERCP pancreatitis risk to levels similar to sphincterotomy. 1

Trade-offs and Risk Profile

  • Increased pancreatitis risk: EPBD without sphincterotomy carries higher risk of post-ERCP pancreatitis compared to sphincterotomy alone 1
  • Lower bleeding risk: EPBD demonstrates significantly lower hemorrhage rates 1
  • Stone clearance: EPBD shows slightly lower stone clearance rates compared to sphincterotomy 1

Contraindications to EPBD

Do not perform EPBD in patients with:

  • Biliary strictures 1
  • Ampullary, pancreatic, or biliary malignancies 1
  • Prior biliary surgery (except cholecystectomy) 1
  • Acute pancreatitis 1
  • Large common bile duct stones (relative contraindication) 1
  • Precut sphincterotomy already performed for biliary access 1

Pancreatitis Prophylaxis

Administer rectal NSAIDs (100 mg diclofenac or indomethacin) immediately before ERCP in all patients without contraindications. 2 This represents strong recommendation with moderate-quality evidence from ESGE guidelines. 2

In patients with high risk of post-ERCP pancreatitis from repeated pancreatic duct cannulation, insert a pancreatic stent in addition to rectal NSAIDs. 1, 2

Overall ERCP Risk Profile

The baseline complication rates for ERCP procedures are:

  • Major complications: 4-5.2% (pancreatitis, cholangitis, hemorrhage, perforation) 1, 3, 4, 5
  • Mortality: 0.4% 1, 3, 4, 5
  • Iatrogenic pancreatitis with sphincterotomy: up to 10% 1, 4, 5

Clinical Algorithm for Decision-Making

For patients with coagulopathy:

  1. Obtain FBC and INR/PT pre-procedure 1
  2. If coagulopathy is uncorrectable, proceed with EPBD alone (no sphincterotomy) 1
  3. Use 8 mm balloon with ≥1 minute inflation 1
  4. Administer rectal NSAIDs for pancreatitis prophylaxis 2
  5. Consider pancreatic stent if difficult cannulation occurs 1, 2

For patients with altered anatomy:

  1. Assess technical feasibility of standard ERCP approach 1
  2. If difficult biliary access anticipated, plan EPBD without sphincterotomy 1
  3. Consider alternative approaches (EUS-guided drainage, percutaneous) if ERCP fails 3

For patients with large stones and normal coagulation:

  1. Perform sphincterotomy first 1
  2. Add EPBD as adjunct to facilitate stone removal 1
  3. This combination achieves 80-95% stone clearance rates 1, 3, 4

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

ERCP Indications and Guidelines

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Indications for ERCP in Biliary Pancreatitis

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

ERCP in Renal Failure: Key Considerations

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.